Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Contineum Therapeutics, Inc. | 0 | reported | 02 Mar 2026 | tx 13+456,833−21,666 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 4.50 USD | |
| 02 Mar 2026 | SALE | Contineum Therapeutics, Inc. | 3,611 | 15.02 USD | |
| 02 Mar 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 0.00 USD | deriv |
| 28 Jan 2026 | SALE | Contineum Therapeutics, Inc. | 2,800 | 14.09 USD | |
| 28 Jan 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 4.50 USD | |
| 28 Jan 2026 | SALE | Contineum Therapeutics, Inc. | 811 | 14.48 USD | |
| 28 Jan 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 0.00 USD | deriv |
| 30 Jan 2026 | GRANT_AWARD | Contineum Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 29 Dec 2025 | SALE | Contineum Therapeutics, Inc. | 3,611 | 12.06 USD | |
| 29 Dec 2025 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 4.50 USD | |
| 29 Dec 2025 | EXERCISE | Contineum Therapeutics, Inc. | 3,611 | 0.00 USD | deriv |
| 28 Apr 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 26,000 | 0.00 USD | deriv |
| 28 Apr 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 260,000 | 0.00 USD | deriv |